Dave Rushton
Founder
of Paradigm Shift Consulting Limited.
Dave Rushton is Founder of Paradigm Shift Consulting Limited, a Good Distribution Practice Consultancy.
Blog
Take a look through our free blogs that cover a number of different areas of Good Distribution Practice (GDP). Each blog addresses primary topics including training, inspections and procedures. If you need any more information or any assistance/training don’t hesitate to contact us by email or phone.
Applying for a WDA(V) (Veterinary Medicines Wholesale Distribution Authorisation) in 2026
What is a WDA(V)? A Wholesale Distribution Authorisation for veterinary medicines (WDA(V)) is the licence required to enable the procurement, sale, storage and distribution of medicines for veterinary purposes. In this blog we will explain who will require a WDA(V) and what the application process...
Application for a Wholesale Distribution Authorisation in 2026
The team at Paradigm Shift are often asked what the Wholesale Distribution Authorisation application process is. Whilst we have written about this subject in the past (Wholesale Dealers' Application and Wholesale Distribution Authorisation Explained), we thought it would be helpful to provide a...
Wholesale Distribution Authorisation (WDA) Explained for 2026
What is a Wholesale Distribution Authorisation (WDA)? Being in possession of a Wholesale Distribution Authorisation (WDA) – the terminology in the EU 2013/C 343/01 guideline - is a legal requirement for any company involved in the procurement, storage, or distribution of human or veterinary...
How to Navigate Medicine Classifications (2026 edition)
Navigating Medicine Classifications, GDP Guidelines and WDA Scope. For pharmaceutical distributors, the moment a product is determined to be a medicinal product, the regulatory landscape changes. Licence obligations, handling, supply chain and recipient eligibility are all affected. ...
Human Error is Not the Root Cause!
Strengthening Root Cause Analysis (RCA) in GDP At a time when the Medicines and Healthcare products Regulatory Agency (MHRA) continues to highlight deficiencies in deviation investigations, one thing is clear… effective root cause analysis is essential for compliance with Good Distribution...
Good Distribution Practice for Veterinary Medicines
Understanding Good Distribution Practice for Veterinary Medicines in Great Britain In June 2025, the Veterinary Medicines Directorate (VMD) introduced the Good Distribution Practice (GDP) for Veterinary Medicinal Products in Great Britain guidelines. This move brings greater regulatory clarity and...
The Real Costs of a WDA: What No One Tells You About Pricing in 2026
WDA(H) Application Costs: What Pharmacies & Pharmaceutical Distributors Need to Know (Update) In the world of pharmaceutical wholesale and distribution, compliance with EU GDP Guidelines, not least holding a valid WDA(H) licence, is essential.Yet Paradigm Shift consultants have found that...
Why GDP Matters to Pharmaceutical Wholesalers
The Importance of GDP Guidelines from Manufacture to Wholesale The quality and safety of medicines depend not only on how they are manufactured, but also on how they are distributed throughout the supply chain by pharmaceutical wholesale distributors, and this is where Good Distribution Practice...
Finalists for North Northamptonshire Business of the Year Award 2025!
Paradigm Shift Consulting Ltd: North Northants Business of the Year 2025 - Finalists Paradigm Shift Consulting Ltd are thrilled to share some exciting news:We have been named as finalists for the North Northamptonshire Business of the Year Award at the prestigious Northamptonshire Business Awards...
ALCOA++ and the Future of Data Integrity in GDP
Why ALCOA++ Matters in Good Documentation Practices (GDP) In the pharmaceutical supply chain, documentation is more than just paperwork, it is the core of product quality, patient safety, and regulatory compliance.As we move further into an era of digital records and increasingly complex...